{"meshTags":["Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Carcinoma, Non-Small-Cell Lung","Colorectal Neoplasms","Female","Humans","Lung Neoplasms","Molecular Targeted Therapy","Precision Medicine","Quinazolines","Receptor, Epidermal Growth Factor","Receptor, ErbB-2","Trastuzumab"],"meshMinor":["Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Carcinoma, Non-Small-Cell Lung","Colorectal Neoplasms","Female","Humans","Lung Neoplasms","Molecular Targeted Therapy","Precision Medicine","Quinazolines","Receptor, Epidermal Growth Factor","Receptor, ErbB-2","Trastuzumab"],"publicationTypes":["Editorial"],"title":"Personalised cancer management: closer, but not here yet.","pubmedId":"23878113"}